Join the Multiple Sclerosis group to help and get support from people like you.
Multiple Sclerosis News (Page 3)
Related terms: MS
Initial Symptoms of MS Could Guide Prognosis, Treatment
WEDNESDAY, Sept. 25, 2024 – Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options,...
Higher Burden of Comorbidity Linked to Worse Clinical Outcomes in MS
MONDAY, Sept. 23, 2024 – For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according to a study published online Sept. 18 in JAMA...
Some People With MS May Need Earlier, Higher-Dose Meds
WEDNESDAY, Sept. 18, 2024 – Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent ...
Multiple Sclerosis Linked to Lower Risk for Alzheimer Disease Pathology
FRIDAY, Aug. 30, 2024 – Multiple sclerosis (MS) is associated with a lower risk for Alzheimer disease, according to a study published in the September issue of the Annals of Neurology. Noting that...
Could Having MS Help Shield Against Alzheimer's Disease?
TUESDAY, Aug. 27, 2024 – People with multiple sclerosis appear to have a lower risk of developing Alzheimer’s disease, a new study suggests. MS patients are far less likely to have elevated blood l...
COVID Vaccine Won't Trigger MS Relapse: Study
WEDNESDAY, Aug. 21, 2024 – Multiple sclerosis makes people vulnerable to more severe cases of COVID-19, but a new study finds that getting the COVID vaccine won't trigger a relapse of MS symptoms....
Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination
WEDNESDAY, Aug. 14, 2024 – For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in...
Most Patients With MS Have No Risk for Relapse After COVID-19 Vaccination
WEDNESDAY, Aug. 14, 2024 – For most patients with multiple sclerosis (MS), there is no increased risk for relapse after COVID-19 vaccination, according to a study published online Aug. 14 in...
New MS Drug Kesimpta May Help Keep Symptoms at Bay
THURSDAY, July 18, 2024 – A new monoclonal antibody treatment called Kesimpta (ofatumumab) appears to improve on an older drug in pushing multiple sclerosis (MS) into remission, a new trial shows....
Ofatumumab Effective for MS Across Racial, Ethnic Subgroups
WEDNESDAY, July 17, 2024 – For patients with relapsing multiple sclerosis (RMS), ofatumumab is more effective than teriflunomide across racial and ethnic subgroups, according to a study published...
Parental Smoking Possibly Linked to Increased Risk for MS
FRIDAY, July 12, 2024 – Exposure to parental smoking (ParS) is associated with an increased risk for multiple sclerosis (MS) in later life in certain populations, according to a study presented at...
Scientists Uncover Links Between MS and Epstein-Barr Virus
WEDNESDAY, June 19, 2024 – The discovery that the Epstein-Barr virus might be a major driver of multiple sclerosis has re-energized research into the autoimmune disease. Now, investigators in the...
FDA Approves Tyruko (natalizumab-sztn), a Biosimilar to Tysabri
August 24, 2023 – The U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing...
Tascenso ODT (fingolimod) Launched to Meet the Needs of Multiple Sclerosis Patients in the US Left Without Essential Patient Support
Tascenso ODT is available to dispense to US multiple sclerosis (MS) patients Tascenso ODT is bioequivalent to, but not a generic of, Gilenya® (fingolimod) capsules1,2 On March 31st 2023 the Gilenya ...
FDA Approves Briumvi (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis
NEW YORK, Dec. 28, 2022 (GLOBE NEWSWIRE) – TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the U.S. Food and Drug Administration (FDA) has approved Briumvi™ (ublituximab-xiiy), for the t...
Further information
Related drug support groups
prednisone, methylprednisolone, Medrol, prednisolone, valacyclovir, dexamethasone, Tecfidera, Ocrevus, Gilenya, dimethyl fumarate, Aubagio